Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)
Sara A. Hurvitz, Jennifer L. Caswell-Jin, Katherine L. McNamara, Jason J. Zoeller, Gregory R. Bean, Robert Dichmann, Alejandra Perez, Ravindranath Patel, Lee Zehngebot, Heather Allen, Linda Bosserman, Brian DiCarlo, April Kennedy, Armando Giuliano, Carmen Calfa, David Molthrop, Aruna Mani, Hsiao-Wang Chen, Judy Dering, Brad Adams, Eran Kotler, Michael F. Press, Joan S. Brugge, View ORCID ProfileChristina Curtis, Dennis J. Slamon
doi: https://doi.org/10.1101/2020.09.16.20194324
Sara A. Hurvitz
1University of California, Los Angeles;
Jennifer L. Caswell-Jin
2Stanford University;
Katherine L. McNamara
2Stanford University;
Jason J. Zoeller
3Harvard University;
Gregory R. Bean
2Stanford University;
Robert Dichmann
4Central Coast Medical Oncology;
Alejandra Perez
5University of Miami;
Ravindranath Patel
6Comprehensive Blood & Cancer Center;
Lee Zehngebot
7Florida Cancer Specialists & Research Institute;
Heather Allen
8Comprehensive Cancer Centers of Nevada;
Linda Bosserman
9City of Hope National Medical Center;
Brian DiCarlo
1University of California, Los Angeles;
April Kennedy
10FCPP Hematology/Oncology;
Armando Giuliano
11Cedars-Sinai Medical Center;
Carmen Calfa
5University of Miami;
David Molthrop
7Florida Cancer Specialists & Research Institute;
Aruna Mani
12Genentech;
Hsiao-Wang Chen
1University of California, Los Angeles;
Judy Dering
1University of California, Los Angeles;
Brad Adams
1University of California, Los Angeles;
Eran Kotler
2Stanford University;
Michael F. Press
13University of Southern California
Joan S. Brugge
3Harvard University;
Christina Curtis
2Stanford University;
Dennis J. Slamon
1University of California, Los Angeles;
Data Availability
Raw expression data are deposited in GEO (GSE130788).
Posted September 18, 2020.
Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)
Sara A. Hurvitz, Jennifer L. Caswell-Jin, Katherine L. McNamara, Jason J. Zoeller, Gregory R. Bean, Robert Dichmann, Alejandra Perez, Ravindranath Patel, Lee Zehngebot, Heather Allen, Linda Bosserman, Brian DiCarlo, April Kennedy, Armando Giuliano, Carmen Calfa, David Molthrop, Aruna Mani, Hsiao-Wang Chen, Judy Dering, Brad Adams, Eran Kotler, Michael F. Press, Joan S. Brugge, Christina Curtis, Dennis J. Slamon
medRxiv 2020.09.16.20194324; doi: https://doi.org/10.1101/2020.09.16.20194324
Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)
Sara A. Hurvitz, Jennifer L. Caswell-Jin, Katherine L. McNamara, Jason J. Zoeller, Gregory R. Bean, Robert Dichmann, Alejandra Perez, Ravindranath Patel, Lee Zehngebot, Heather Allen, Linda Bosserman, Brian DiCarlo, April Kennedy, Armando Giuliano, Carmen Calfa, David Molthrop, Aruna Mani, Hsiao-Wang Chen, Judy Dering, Brad Adams, Eran Kotler, Michael F. Press, Joan S. Brugge, Christina Curtis, Dennis J. Slamon
medRxiv 2020.09.16.20194324; doi: https://doi.org/10.1101/2020.09.16.20194324
Subject Area
Subject Areas
- Addiction Medicine (375)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2763)
- Dermatology (236)
- Emergency Medicine (414)
- Epidemiology (12413)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4275)
- Geriatric Medicine (396)
- Health Economics (702)
- Health Informatics (2763)
- Health Policy (1023)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (455)
- Neurology (4058)
- Nursing (218)
- Nutrition (601)
- Oncology (2139)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (479)
- Pediatrics (1150)
- Primary Care Research (471)
- Public and Global Health (6663)
- Radiology and Imaging (1455)
- Respiratory Medicine (886)
- Rheumatology (423)
- Sports Medicine (353)
- Surgery (466)
- Toxicology (57)
- Transplantation (193)
- Urology (171)